Home/Filings/8-K/0001493152-25-029216
8-K//Current report

Glucotrack, Inc. 8-K

Accession 0001493152-25-029216

$GCTKCIK 0001506983operating

Filed

Dec 28, 7:00 PM ET

Accepted

Dec 29, 8:11 AM ET

Size

11.8 MB

Accession

0001493152-25-029216

Research Summary

AI-generated summary of this filing

Updated

Glucotrack, Inc. Files Investor Presentation Under Regulation FD

What Happened

  • On December 29, 2025, Glucotrack, Inc. filed a Form 8-K to report a Regulation FD disclosure, furnishing an investor presentation as Exhibit 99.1. The filing also includes the Cover Page Interactive Data File (Inline XBRL).
  • The 8-K does not report other changes (such as executive changes or earnings) beyond the furnished presentation.

Key Details

  • Filing date: December 29, 2025.
  • Exhibit provided: 99.1 — Investor Presentation dated December 29, 2025.
  • Regulation: Disclosure made under Item 7.01 (Regulation FD Disclosure).
  • Additional exhibit: Item 9.01 includes the Inline XBRL Cover Page Interactive Data File (Exhibit 104).

Why It Matters

  • The company has publicly furnished its latest investor presentation, which is now part of the SEC record (Exhibit 99.1). Under Regulation FD, this means Glucotrack intended the information to be broadly available to all investors at the same time.
  • Investors should review the presentation on the SEC EDGAR site or the company’s investor relations page to see any updates on strategy, programs, or metrics disclosed in the slides.